Abstract
This thesis aimed to explore the potential of COVID-19 vaccination and passive immunization in immunocompromised patients with hematologic malignancies, who faced disproportionately high COVID-19-related morbidity and mortality.
Chapters 2-4 show that intensified COVID-19 mRNA vaccination induced robust antibody and T cell responses in the majority of patients with hematologic
Chapters 2-4 show that intensified COVID-19 mRNA vaccination induced robust antibody and T cell responses in the majority of patients with hematologic
| Original language | English |
|---|---|
| Qualification | Doctor of Philosophy |
| Awarding Institution |
|
| Supervisors/Advisors |
|
| Award date | 11 Jul 2025 |
| Publication status | Published - 2025 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'COVID-19 vaccine immunogenicity and population-based outcome studies in patients with hematologic malignancies'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver